Aflac (AFL) Insider Joseph Moskowitz Buys $905K of Stock
Joseph Moskowitz purchased over 20,000 shares of Aflac, reflecting a significant investment.
Reviewed by automated data checks against the source filing. How we make and check alerts
Joseph Moskowitz bought 20,303 shares of Aflac Incorporated ($AFL) at an average price of $44.59, worth about $905,310.77, on June 22, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $AFL is up 3.0% after 1 week, up 6.0% after 1 month and up 3.5% to date (from the $115.97 close on Jun 22, 2026).
AFL
Aflac Incorporated
Key Points
- Joseph Moskowitz bought 20,303 shares of Aflac at $44.59 each, totaling $905,310.77 on June 22, 2026.
- Aflac shares traded near $117.58 on Wednesday, with a market cap of $59.3 billion and a P/E ratio of 13.32.
- Vanguard Portfolio Management opened a new position in Aflac, while Geode Capital Management increased its stake by 2.4%.
Get $AFL trade alerts by text
We text you when insiders, Congress or big funds trade $AFL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Aflac Incorporated alert may contain errors. Disclosures
Joseph Moskowitz recently made a significant purchase of Aflac Incorporated (NYSE:AFL) shares. On June 22, 2026, he acquired 20,303 shares at an average price of $44.59 each, totaling approximately $905,310.77. This transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Aflac Incorporated
On June 22, 2026, Joseph Moskowitz increased his holdings in Aflac by purchasing 20,303 shares at $44.59 each. This transaction amounted to a total value of $905,310.77. The purchase was conducted as a direct buy and not under a Rule 10b5-1 trading plan.
Other Institutional Activity in Aflac Incorporated
Several other institutional investors have also been active in Aflac. Vanguard Capital Management LLC opened a new position, acquiring 30,254,403 shares valued at about $3.32 billion. Similarly, Vanguard Portfolio Management LLC initiated a stake with 18,242,564 shares worth approximately $2.00 billion. Meanwhile, Geode Capital Management, LLC increased its holdings by 248,274 shares, ending with 10,717,264 shares valued at around $1.17 billion, marking a 2.4% increase. In contrast, Japan Post Holdings Co., Ltd. and BlackRock, Inc. reduced their stakes by 0.6% and 1.6%, respectively.
Aflac Incorporated Stock Down 0.2%
As of Wednesday, shares of Aflac Incorporated (NYSE:AFL) were trading near $117.58. The company, with a market cap of approximately $59.3 billion, has a P/E ratio of 13.32 and a beta of 0.61, indicating lower volatility compared to the market. The stock has a 52-week range between $96.95 and $119.81, with a 50-day moving average of $115.10 and a 200-day moving average of $111.45.
Recent Earnings
Aflac reported revenue of $18.1 billion with a growth rate of 27.9%. The company has a net margin of 25.6% and a return on equity of 16.5%. Earnings per share stood at $8.75. Aflac is expected to announce its next earnings on August 6, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target raises vs 2 cuts.
-
EPS & revenue
EPS missed estimates by 4.4%. Revenue beat estimates by 1.1%.
-
Profit surprise
Operating income beat by 13 percent.
-
Pre-earnings setup
Bar was low, analysts cautious going in.
-
Analyst signal
2 target raises, 2 target cuts.
-
Earnings quality
Gross margin up 43.4 points. Operating margin up 24.2 points.
Earnings Call Summary
Aflac Japan delivered strong sales growth of 25.5 percent in the quarter, driven by new medical and cancer insurance products, though underlying earned premiums still declined 1.3 percent due to lapses of paid-up policies. In the United States, net earned premiums grew 3.5 percent with solid persistency of 79.3 percent. Management noted that Japan would need about 80 billion yen in annual sales to reach flat earned premium growth, versus 74 billion achieved in 2025.
Guidance Aflac expects Japan benefit ratio between 60 percent and 63 percent for the full year, roughly in line with first quarter results. For the United States, they forecast a benefit ratio of 42 percent to 52 percent. The company plans to continue share buybacks and dividend increases, returning $1.3 billion to shareholders in the first quarter alone.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Dividend
Aflac offers an annual dividend rate of $2.44, yielding 2.11% with a payout ratio of 26.86%. This provides investors with a steady income stream.
Analysts Set New Price Targets
On May 26, 2026, Piper Sandler maintained a 'buy' rating for Aflac with a price target of $130. Morgan Stanley, on May 21, 2026, kept a 'hold' rating with a target of $125. The consensus among 14 analysts is a 'hold' rating, with an average target price of $112.43.
About Aflac Incorporated
Aflac Incorporated, based in Columbus, Georgia, provides supplemental health and life insurance products. It operates through two main segments: Aflac Japan and Aflac U.S. The company offers a variety of insurance products, including cancer, medical, and life insurance, serving individuals, families, and businesses. Founded in 1955, Aflac is led by CEO Daniel Paul Amos and employs over 12,700 people.
Bottom Line
Joseph Moskowitz's recent purchase highlights a notable investment in Aflac. While insider transactions are closely watched, they are just one factor in evaluating a company's stock. Aflac's current financials and analyst ratings suggest a stable outlook, though investors should consider various factors before making decisions.
Related Filing Alerts
Source: Joseph Moskowitz's Form 4 filing on $AFL (Jun 22, 2026). Find the original filing: AFL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts